Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




AACR-NCI-EORTC 2009 International Conference on Molecular Targets and Cancer Therapeutics
Link ID 20461
Title AACR-NCI-EORTC 2009 International Conference on Molecular Targets and Cancer Therapeutics
Url http://www.medscape.com/viewcollection/30574?src=rss
Description Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Nov 26, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Laparoscopic Cryoablation Safe, Feasible for Larger Renal Tumors
  Despite increased perioperative complications, laparoscopic cryotherapy was safe and feasible for tumors larger than 3 cm, with no increased risk for bleeding, according to a European multicenter prospective trial. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. An Oncologist Muses About the Power of Words
  Mindful of the ripple effect of words, in this video blog, Dr. John Marshall urges oncologists to be sensitive to the "life and death" power of their messages.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. First Formal Guidelines for Cancer Survivorship First Formal Guidelines for Cancer Survivorship
  Physicians have a unique opportunity to guide cancer survivors toward optimal lifestyle choices that could improve survival, a new report says. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. FDA Safety Changes: Campath and Trileptal
  The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Control of Colon Cancer Development and Progression by Selected Estrogen Receptor Modulators
  Estrogens behave as protective agents on the development of colorectal cancer, and hormonal-replacement therapy is associated with an increased survival rate in women with this disease.
Expert Review of Endocrinology and Metabolism
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS